NICE blames Faslodex rejection on uncertainties in AZ data
August 23, 2011Sales and Marketing AstraZeneca, Faslodex, NICE, breast cancer
NICE has not recommended a high-dose form of AstraZeneca’s breast cancer drug Faslodex because of uncertainties over its cost-effectiveness. In …
GSK invests in UK biotech start-up
August 22, 2011Research and Development Autifony, GSK, biotech, hearing loss, research and development news
GlaxoSmithKline has taken a £1.3 million stake in a new UK biotech spin-out that will develop pharmacological treatments for hearing …
Generic user fees could boost FDA inspection powers
August 22, 2011Manufacturing and Production Mylan, generics, pharma manufacturing news
Generic drugmakers have forged a tentative deal with the US government that could see user fees being used to help …
BMS launches skin cancer treatment Yervoy in UK
August 22, 2011Sales and Marketing Yervoy, cancer vaccine, ipilimumab, skin cancer
Bristol-Myers Squibb’s skin cancer treatment Yervoy has been launched in the UK for patients with the deadliest form of the …
Double Helix expands strategic market research team
August 22, 2011Medical Communications, Sales and Marketing appointment, medical communications, sales and marketing
Global market research consultancy Double Helix has appointed Fiona Bailey and Anwar Kumi to the positions of associate director and …
J&J’s latest recall put down to new factor
August 19, 2011Manufacturing and Production J&J, JJ, Tylenol, recalls
Yet another Johnson & Johnson recall has been announced, but this time the perpetrator doesn’t feature among the ‘usual suspects’. …
Pharma manufacturing news in brief
August 19, 2011Manufacturing and Production pharma manufacturing news
Lonza launches a stripped down material supply service for biologics developers, plus facility news from United Therapeutics, Dr Reddy’s and …
EMA to review two new Pfizer cancer drugs
August 19, 2011Sales and Marketing Cancer, Pfizer, bosutinib, crizotinib
The EMA has accepted Pfizer’s regulatory submissions for two of its new cancer compounds. The first is its much-lauded crizotinib, …
Idea Pharma boosts project management team
August 19, 2011Sales and Marketing appointment, sales and marketing
Phase II strategy consultancy Idea Pharma has appointed two new project managers to its team – Suzanne Axford-Bryars and Lidia …
OPEN Health launches research service
August 19, 2011Medical Communications Open Health, medical communications agency
Healthcare communications agency OPEN Health, has launched OPEN Plan, a market research and brand planning specialist team. The company says …
Roche’s Zelboraf approved by FDA months ahead of schedule
August 18, 2011Sales and Marketing Yervoy, Zelboraf, skin cancer
The FDA has approved Roche and Daiichi Sankyo’s new skin cancer drug Zelboraf two months ahead of schedule. Zelboraf (vemurafenib) …
Virgo Health appoints GSK’s Rebecca Neil
August 18, 2011Medical Communications appointments, medical communications
Healthcare comms agency Virgo Health has appointed GlaxoSmithKline’s Rebecca Neil to its education team. Rebecca spent six years at the …
New discount persuades NICE to back Novartis’ Tasigna
August 18, 2011Sales and Marketing Glivec, NICE, Sprycel, Tasigna
NICE has recommended Novartis’ Tasigna for use in the NHS after the blood cancer drug’s manufacturer submitted a new patient …
6 challenges facing pharma communications
August 18, 2011Medical Communications communications, emerging markets
Brian O’Riordan looks at how the pharma industry is adapting to the changing world of 21st Century communications. 1) New …
Joint API inspection pilot proves successful
August 17, 2011Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Wainwright Associates
Over recent years compliance with GMP in the manufacture of active substances (APIs) has been the subject of increasing regulatory …
Digital Pharma: Bayer reprimanded over social media use
August 17, 2011Medical Communications ABPI Code of Practice, Bayer, Digital Pharma blog, PMCPA
Bayer will be named in the medical press after being found guilty of the first social media breach of the …
NICE to review Lucentis decision
August 17, 2011Sales and Marketing Lucentis, NICE, diabetic macular edema
NICE will allow an appeal against its decision not to recommend Novartis’s Lucentis for diabetic macular oedema. The appeal came …
Sanofi Pasteur MSD appoints new UK medical director
August 17, 2011Research and Development, Sales and Marketing appointment, research and development, sales and marketing
Sanofi Pasteur MSD has appointed Dr Aidrian Kilcoyne as medical director in the UK. He joins the company from Roche …
NICE wants more information on Pradaxa
August 17, 2011Sales and Marketing NICE, Pradaxa
NICE has asked for more information on Pradaxa, after deciding in preliminary guidance that the drug is not cost-effective in …
Pfizer triumphs in US Viagra patent trial
August 17, 2011Sales and Marketing Pfizer, generics, viagra
Pfizer has won a US patent infringement case against generics giant Teva, stopping the company from making its own version …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
